Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
3P50DA001696-18S1
Application #
6103947
Study Section
Project Start
1997-03-01
Project End
2000-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
18
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Herbst, Ellen D; Harris, Debra S; Everhart, E Thomas et al. (2011) Cocaethylene formation following ethanol and cocaine administration by different routes. Exp Clin Psychopharmacol 19:95-104
Batki, Steven L; Harris, Debra S (2004) Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am J Addict 13:461-70
Delucchi, Kevin L; Batki, Steven L; Moon, Julia et al. (2002) Urine toxicology samples in cocaine treatment trials: how many need to be tested? J Addict Dis 21:17-26
Harris, D; Batki, S L (2000) Stimulant psychosis: symptom profile and acute clinical course. Am J Addict 9:28-37
Dempsey, D A; Hajnal, B L; Partridge, J C et al. (2000) Tone abnormalities are associated with maternal cigarette smoking during pregnancy in in utero cocaine-exposed infants. Pediatrics 106:79-85
Batki, S L; Moon, J; Delucchi, K et al. (2000) Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis. Ann N Y Acad Sci 909:260-3
Delucchi, K L; Jones, R T; Batki, S L (1997) Measurement properties of quantitative urine benzoylecgonine in clinical trials research. Addiction 92:297-302
Batki, S L; Washburn, A M; Delucchi, K et al. (1996) A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 41:137-42
Herbst, M D; Batki, S L; Manfredi, L B et al. (1996) Treatment outcomes for methadone clients receiving lump-sum payments at initiation of disability benefits. Psychiatr Serv 47:119-20, 142